This list is an analysis based on recent market events. It's not an investment recommendation.
About
Coiled Therapeutics plc, a clinical-stage oncology company, develops and commercialises clinical-stage oncology therapeutics in the United Kingdom and internationally. The company's lead asset is AO-252, a first-in-class, small molecule inhibitor of TACC3, currently in a Phase I clinical trial for advanced solid tumours, including ovarian and prostate cancer. The company also offers a STAT-6 siRNA programme targeting immunology indications such as asthma, fibrosis, eczema, and allergic disease, with plans for assessment towards Phase I clinical trials. The company is based in London, United Kingdom.
The current price of COTXF is $0.11 USD — it has increased by +0% in the past 24 hours. Watch Coiled Therapeutics stock price performance more closely on the chart.
What is Coiled Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Coiled Therapeutics stocks are traded under the ticker COTXF.
What is Coiled Therapeutics market cap?▼
Today Coiled Therapeutics has the market capitalization of 17.52M
What is Coiled Therapeutics revenue for the last year?▼
Coiled Therapeutics revenue for the last year amounts to 0 USD.
What is Coiled Therapeutics net income for the last year?▼
COTXF net income for the last year is -4.54M USD.
In which sector is Coiled Therapeutics located?▼
Coiled Therapeutics operates in the Other sector.
When did Coiled Therapeutics complete a stock split?▼
Coiled Therapeutics has not had any recent stock splits.
Where is Coiled Therapeutics headquartered?▼
Coiled Therapeutics is headquartered in London, United Kingdom.